Cargando…
Residual or Recurrent Precancerous Lesions After Treatment of Cervical Lesions in Human Immunodeficiency Virus–infected Women: A Systematic Review and Meta-analysis of Treatment Failure
BACKGROUND: Screening and treating premalignant cervical lesions (cervical intraepithelial neoplasia 2+ [CIN2+]) is an effective way to prevent cervical cancer, and recommendations exist for the monitoring of treatment success. Yet, there is no specific recommendation for human immunodeficiency viru...
Autores principales: | Debeaudrap, Pierre, Sobngwi, Joelle, Tebeu, Pierre-Marie, Clifford, Gary M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792085/ https://www.ncbi.nlm.nih.gov/pubmed/30602038 http://dx.doi.org/10.1093/cid/ciy1123 |
Ejemplares similares
-
Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa
por: Viviano, Manuela, et al.
Publicado: (2017) -
Efficacy of thermoablation in treating cervical precancerous lesions in a low-resource setting
por: Tran, Phuong Lien, et al.
Publicado: (2017) -
A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa
por: Viviano, Manuela, et al.
Publicado: (2017) -
Immunologic treatments for precancerous lesions and uterine cervical cancer
por: Vici, Patrizia, et al.
Publicado: (2014) -
Acceptability and safety of thermal ablation for the treatment of precancerous cervical lesions in Honduras
por: Sandoval, Manuel, et al.
Publicado: (2019)